Redpin Therapeutics Competitors and Similar CompaniesClear all
Redpin Therapeutics's competitors and similar companies include Precigen, Ocugen, Cell Therapies and ProQR Therapeutics.
 Redpin Therapeutics Redpin Therapeutics is a gene therapy company providing cell therapies that address diseases of the nervous system. |  Precigen Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases. |  Ocugen Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies to treat eye diseases |  Cell Therapies Cell Therapies is a manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products. |  ProQR Therapeutics ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases. | |
Founding Date | Founding Date 2017 | Founding Date 1998 | Founding Date 2013 | Founding Date 2003 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations New York, US HQ New York, US | Locations Germantown, US HQ Gent, BE Sioux Center, US | Locations Malvern, US HQ | Locations Melbourne, AU HQ | Locations Leiden, NL HQ Cambridge, US |
Employees | Employees 2 | Employees 601 | Employees 84425% increase | Employees 733% decrease | Employees 166 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 246.6 m | Valuation ($) 292.1 m | Valuation ($) N/A | Valuation ($) 281.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.7m (FY, 2025) | Revenue (est.) $4.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €15.9m (FY, 2025) |
Net income | Net income N/A | Net income ($250.6m) (FY, 2025) | Net income ($67.8m) (FY, 2025) | Net income N/A | Net income (€42.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 17m | Total funding raised $ 379m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 57.8m |
For sources of this data, please see the company profile
View Company Profiles
Precigen
HQ
Germantown, US
Employees
601
Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases.
View companyOcugen
HQ
Malvern, US
Employees
84
Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies to treat eye diseases
View companyCell Therapies
HQ
Melbourne, AU
Employees
73↓ 3% decrease
Cell Therapies is a manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products.
View companyProQR Therapeutics
HQ
Leiden, NL
Employees
166
ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.
View company